Influence of Induction Therapy On the Efficacy of Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients

被引：0

作者：

Vincenti, F. ^{[1
]}

Qazi, Y. ^{[1
]}

Kaplan, B. ^{[1
]}

Kim, D. ^{[1
]}

Shihab, F. ^{[1
]}

McCague, K. ^{[1
]}

Patel, D. ^{[1
]}

Mulgaonkar, S. ^{[1
]}

Shaffer, D. ^{[1
]}

机构：

[1] CRAD001AUS92, Study Grp, Salt Lake City, UT USA

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2014年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

B966

引用

页码：539 / 540

页数：2

共 50 条

[1] Influence of Induction Therapy On the Efficacy of Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients.
Vincenti, F.
Qazi, Y.
Kaplan, B.
Kim, D.
Shihab, F.
McCague, K.
Patel, D.
Mulgaonkar, S.
Shaffer, D.
[J]. TRANSPLANTATION, 2014, 98 : 539 - 540
[2] Reduced Incidence of CMV and BK Virus Infection With Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients
Shihab, F.
Shaffer, D.
Qazi, Y.
Kaplan, B.
Vincenti, F.
McCague, K.
Patel, D.
Mulgaonkar, S.
Peddi, V.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 537 - 537
[3] Reduced Incidence of CMV and BK Virus Infection With Everolimus vs Mycophenolate Based Regimen in De Novo Renal Transplant Recipients.
Shihab, F.
Shaffer, D.
Qazi, Y.
Kaplan, B.
Vincenti, F.
McCague, K.
Patel, D.
Mulgaonkar, S.
Peddi, V.
[J]. TRANSPLANTATION, 2014, 98 : 537 - 537
[4] EVEROLIMUS BASED/CNI FREE REGIMEN IN DE-NOVO RENAL TRANSPLANT RECIPIENTS
Fior, Francesca
Nacchia, Francesco
Ngoufet, Rostand M.
Rugiu, Carlo
Ghimenton, Claudio
Andreotti, Cristina
Boschiero, Luigi
[J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 180 - 181
[5] Efficacy and Safety of an Everolimus- vs. a Mycophenolate Mofetil-Based Regimen in Pediatric Renal Transplant Recipients
Brunkhorst, Lena Caroline
Fichtner, Alexander
Hoecker, Britta
Burmeister, Greta
Ahlenstiel-Grunow, Thurid
Krupka, Kai
Bald, Martin
Zapf, Antonia
Toenshoff, Burkhard
Pape, Lars
[J]. PLOS ONE, 2015, 10 (09):
[6] Effect of Everolimus With Low Dose Tacrolimus Vs Mycophenolate With Standard Tacrolimus Regimen in African-American De Novo Renal Transplant Recipients
Peddi, V.
Qazi, Y.
Shaffer, D.
Luan, F.
Shihab, F.
Tomlanovich, S.
McCague, K.
Patel, D.
Mulgaonkar, S.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 536 - 536
[7] EVEROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS
Prokopenko, E. I.
[J]. VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2010, 12 (02): : 74 - 81
[8] Effect of Everolimus With Low Dose Tacrolimus Vs Mycophenolate With Standard Tacrolimus Regimen in African-American De Novo Renal Transplant Recipients.
Peddi, V.
Qazi, Y.
Shaffer, D.
Luan, F.
Shihab, F.
Tomlanovich, S.
McCague, K.
Patel, D.
Mulgaonkar, S.
[J]. TRANSPLANTATION, 2014, 98 : 536 - 536
[9] Everolimus (Certican) 12-month safety and efficacy versus mycophenolate mofetil in de novo renal transplant recipients
Vitko, S
Margreiter, R
Weimar, W
Dantal, J
Viljoen, HG
Li, YL
Jappe, A
Cretin, N
[J]. TRANSPLANTATION, 2004, 78 (10) : 1532 - 1540
[10] 12-MONTH ATHENA STUDY: EVEROLIMUS VS. STANDARD REGIMEN IN DE NOVO RENAL TRANSPLANT RECIPIENTS
Witzke, O.
Opgenoorth, M.
Sommerer, C.
Suwelack, B.
Lehner, F.
Dragun, D.
Hauser, I. A.
Schenker, P.
Baeumer, D.
Nashan, B.
Thaiss, F.
[J]. TRANSPLANT INTERNATIONAL, 2014, 27 : 51 - 51

← 1 2 3 4 5 →